This company has been marked as potentially delisted and may not be actively trading. Bioanalytical Systems (BASI) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock BASI vs. NOTV, AIKI, ONMD, LUNA, BIAF, ISPC, DKDCA, IQV, ICLR, and INCYShould you be buying Bioanalytical Systems stock or one of its competitors? The main competitors of Bioanalytical Systems include Inotiv (NOTV), AIkido Pharma (AIKI), OneMedNet (ONMD), Luna Innovations (LUNA), bioAffinity Technologies (BIAF), iSpecimen (ISPC), Data Knights Acquisition (DKDCA), IQVIA (IQV), ICON Public (ICLR), and Incyte (INCY). Bioanalytical Systems vs. Inotiv AIkido Pharma OneMedNet Luna Innovations bioAffinity Technologies iSpecimen Data Knights Acquisition IQVIA ICON Public Incyte Inotiv (NASDAQ:NOTV) and Bioanalytical Systems (NASDAQ:BASI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, community ranking, earnings, profitability, valuation, dividends and institutional ownership. Which has more risk & volatility, NOTV or BASI? Inotiv has a beta of 3.96, indicating that its stock price is 296% more volatile than the S&P 500. Comparatively, Bioanalytical Systems has a beta of 1.92, indicating that its stock price is 92% more volatile than the S&P 500. Which has better valuation and earnings, NOTV or BASI? Bioanalytical Systems has lower revenue, but higher earnings than Inotiv. Bioanalytical Systems is trading at a lower price-to-earnings ratio than Inotiv, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInotiv$475.11M0.13-$108.44M-$4.61-0.41Bioanalytical Systems$60.47M0.34-$4.68M-$0.35-5.34 Does the media prefer NOTV or BASI? In the previous week, Inotiv had 2 more articles in the media than Bioanalytical Systems. MarketBeat recorded 2 mentions for Inotiv and 0 mentions for Bioanalytical Systems. Inotiv's average media sentiment score of 0.93 beat Bioanalytical Systems' score of 0.00 indicating that Inotiv is being referred to more favorably in the media. Company Overall Sentiment Inotiv Positive Bioanalytical Systems Neutral Do insiders and institutionals hold more shares of NOTV or BASI? 18.2% of Inotiv shares are held by institutional investors. Comparatively, 10.6% of Bioanalytical Systems shares are held by institutional investors. 7.8% of Inotiv shares are held by company insiders. Comparatively, 11.5% of Bioanalytical Systems shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community prefer NOTV or BASI? Bioanalytical Systems received 109 more outperform votes than Inotiv when rated by MarketBeat users. However, 48.72% of users gave Inotiv an outperform vote while only 36.26% of users gave Bioanalytical Systems an outperform vote. CompanyUnderperformOutperformInotivOutperform Votes1948.72% Underperform Votes2051.28% Bioanalytical SystemsOutperform Votes12836.26% Underperform Votes22563.74% Is NOTV or BASI more profitable? Bioanalytical Systems has a net margin of -7.75% compared to Inotiv's net margin of -25.40%. Inotiv's return on equity of -15.41% beat Bioanalytical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Inotiv-25.40% -15.41% -3.58% Bioanalytical Systems -7.75%-42.74%-6.38% Do analysts recommend NOTV or BASI? Inotiv currently has a consensus target price of $5.92, suggesting a potential upside of 216.40%. Given Inotiv's stronger consensus rating and higher possible upside, research analysts plainly believe Inotiv is more favorable than Bioanalytical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inotiv 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Bioanalytical Systems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryInotiv beats Bioanalytical Systems on 12 of the 18 factors compared between the two stocks. Get Bioanalytical Systems News Delivered to You Automatically Sign up to receive the latest news and ratings for BASI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BASI vs. The Competition Export to ExcelMetricBioanalytical SystemsCommercial Physical Research IndustryMedical SectorNASDAQ ExchangeMarket Cap$20.82M$2.99B$5.44B$7.80BDividend YieldN/A2.83%5.43%4.30%P/E Ratio-4.4587.7522.1418.40Price / Sales0.34138.59389.70101.29Price / Cash558.4034.5738.2034.62Price / Book2.712.336.664.18Net Income-$4.68M$113.28M$3.21B$247.71M Bioanalytical Systems Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BASIBioanalytical SystemsN/A$1.87-2.6%N/A-55.2%$20.82M$60.47M-4.45397High Trading VolumeNOTVInotiv1.5427 of 5 stars$1.61-1.8%$5.92+267.5%-56.4%$54.29M$475.11M-0.352,100AIKIAIkido PharmaN/A$3.99+3.6%N/A+66.7%$21.89M$10,000.00-1.034News CoverageONMDOneMedNet0.7704 of 5 stars$0.45-0.1%N/A-31.6%$13.83M$957,651.00-1.252Gap DownLUNALuna Innovations1.5972 of 5 stars$0.40+33.3%$8.00+1,900.0%-83.9%$13.58M$116.61M0.00390Analyst ForecastGap UpBIAFbioAffinity Technologies2.615 of 5 stars$0.50-3.6%$6.00+1,108.2%-79.3%$9.06M$9.36M-0.6110ISPCiSpecimen1.4048 of 5 stars$1.18-4.5%N/A+346.1%$2.95M$9.29M-0.0660Negative NewsDKDCAData Knights AcquisitionN/A$0.45-4.3%N/A-33.9%$2.33MN/A-2.372High Trading VolumeIQVIQVIA4.9157 of 5 stars$141.38-1.8%$241.50+70.8%-35.8%$24.93B$15.41B18.8586,000Analyst DowngradeGap DownICLRICON Public4.026 of 5 stars$137.23-1.5%$232.67+69.5%-51.7%$11.08B$8.28B14.4041,100Upcoming EarningsINCYIncyte4.8706 of 5 stars$56.80-2.4%$74.69+31.5%+15.6%$10.99B$4.24B210.382,320Upcoming Earnings Related Companies and Tools Related Companies Inotiv Competitors AIkido Pharma Competitors OneMedNet Competitors Luna Innovations Competitors bioAffinity Technologies Competitors iSpecimen Competitors Data Knights Acquisition Competitors IQVIA Competitors ICON Public Competitors Incyte Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BASI) was last updated on 4/26/2025 by MarketBeat.com Staff From Our PartnersDonald Trump is about to free crypto from its chains …Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election...Weiss Ratings | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredJames Altucher: Do not invest in AI unless…I made millions during the crypto boom. Many “experts” are now saying… Artificial Intelligence opportuni...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredIt’s absolute chaos in Silicon Valley right now…If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioanalytical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioanalytical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BASI Stock Free BASI Stock Alerts